Clinical trials: Aflatoxin Ingestion
Aflatoxin Ingestion
Mycotoxin Mitigation Trial
Multiple observational studies show an association between fetal and post-natal aflatoxin exposure and reduced linear growth. However, the effects of confounding factors such as socio-economic status, food insecurity and nutrient…
- Trial name
- MMT (NCT03940547)
- Testing
- Provision of flour, Promotion of flour
- Where
- Tanzania
- Volunteers
- 2,842 people
- Sponsor
- Cornell University
Dietary Carcinogenesis
Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"
The primary purpose of the study is to evaluate the effectiveness of a naturally occurring clay substance (ACCS100) in reducing harmful effects of aflatoxin exposure (a carcinogen) and fumonisin (a cancer promoter).
- Trial name
- RDMEACCS100 (NCT01677195)
- Testing
- ACCS100
- Where
- United States
- Volunteers
- 234 people, healthy volunteers welcome
- Sponsor
- Texas Enterosorbents Incorporated